InsidersTradesSigma
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by KOTLER KEVIN, Director. Officer active across 1 companies, notably Biodelivery Sciences International INC. In total, 14 filings have been logged. Total volume traded: €3.4m. The latest transaction was disclosed on 22 March 2022 — J. Regulator: SEC (Form 4). The full history is openly available.
Declarations14 total
07,588,395 shares0
Common Stock
SEC:0001103021-22-000069:0·
€4m2,422,222 shares@ €1.576852.7% of flow
Common Stock
SEC:0001103021-22-000047:0·
07,684 shares0
Common Stock
SEC:0001103021-22-000022:0·
07,684 shares0
Common Stock
SEC:0001103021-22-000022·
€269,167100,000 shares@ €2.691715.7% of flow
Common Stock
SEC:0001103021-21-000120·
Ideal exit: 16 Aug 2022 (T+270)
€269,167100,000 shares@ €2.69173.7% of flow
Common Stock
SEC:0001103021-21-000120:0·
Ideal exit: 16 Aug 2022 (T+270)
€279,456100,000 shares@ €2.794616.3% of flow
Common Stock
SEC:0001103021-21-000114·
Ideal exit: 9 Aug 2022 (T+270)
€279,456100,000 shares@ €2.79463.9% of flow
Common Stock
SEC:0001103021-21-000114:0·
Ideal exit: 9 Aug 2022 (T+270)
€774,157257,800 shares@ €3.002945.2% of flow
Common Stock
SEC:0001103021-21-000110·
Ideal exit: 2 Aug 2022 (T+270)
€774,157257,800 shares@ €3.002910.7% of flow
Common Stock
SEC:0001103021-21-000110:0·
Ideal exit: 2 Aug 2022 (T+270)
030,000 shares0
Common Stock
SEC:0001103021-21-000072·
030,000 shares0
Common Stock
SEC:0001103021-21-000072:0·
€390,300150,000 shares@ €2.60222.8% of flow
Common Stock
SEC:0001103021-21-000046·
Ideal exit: 5 Feb 2022 (T+270)
€390,300150,000 shares@ €2.6025.4% of flow
Common Stock
SEC:0001103021-21-000046:0·
Ideal exit: 5 Feb 2022 (T+270)
14 of 14 declarations
About KOTLER KEVIN
Kevin Kotler is a Board Member at BioDelivery Sciences International Inc. With expertise in the pharmaceutical field, he contributes to the governance and strategy of the company. His role on the board is essential for guiding product development initiatives and ensuring regulatory compliance.
